_id

690f3781ccc777a4e85d17ed

Ticker

BOLT

Name

Bolt Biotherapeutics

Exchange

NASDAQ

Address

900 Chesapeake Drive, Redwood City, CA, United States, 94063

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.boltbio.com

Description

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc.; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Last Close

5.86

Volume

14936

Current Price

5.935

Change

1.2798634812286567

Last Updated

2025-11-28T13:04:24.348Z

Image

data:image/webp;base64,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

Ipo Date

2021-02-05T00:00:00.000Z

Market Cap

9501238

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9485

Sentiment Sources

2

Rating

3.5

Target Price

22

Strong Buy

1

Buy

0

Hold

3

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

2169000

Cost Of Revenue

290000

Gross Profit

1879000

Operating Expenses

9582000

Operating Income

-7703000

Interest Expense

-

Pretax Income

-7144000

Net Income

-7144000

Eps

-3.7219169539464874

Dividends Per Share

-

Shares Outstanding

1919441

Income Tax Expense

-

EBITDA

-6854000

Operating Margin

-355.14061779621943

Total Other Income Expense Net

559000

Cash

17753000

Short Term Investments

14157000

Receivables

-

Inventories

-

Total Current Assets

35606000

Property Plant Equipment

21381000

Total Assets

65053000

Payables

1518000

Short Term Debt

2700000

Long Term Debt

-

Total Liabilities

32952000

Equity

32101000

Depreciation

290000

Change In Working Capital

-3791000

Cash From Operations

-9732000

Capital Expenditures

72000

Cash From Investing

17884000

Cash From Financing

0

Net Change In Cash

8152000

PE

-

PB

0.34680408086975484

ROE

-22.25475841874085

ROA

-10.98181482790955

FCF

-9804000

Fcf Percent

-4.520055325034578

Piotroski FScore

0

Health Score

23

Deep Value Investing Score

5.5

Defensive Investing Score

6

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

3

Growth Investing Score

2.5

Momentum Investing Score

4.5

Net Net Investing Score

4

Quality Investing Score

2

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

2169000

Quarters > 0 > income Statement > cost Of Revenue

290000

Quarters > 0 > income Statement > gross Profit

1879000

Quarters > 0 > income Statement > operating Expenses

9582000

Quarters > 0 > income Statement > operating Income

-7703000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-7144000

Quarters > 0 > income Statement > net Income

-7144000

Quarters > 0 > income Statement > eps

-3.7219169539464874

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

1919441

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-6854000

Quarters > 0 > income Statement > operating Margin

-355.14061779621943

Quarters > 0 > income Statement > total Other Income Expense Net

559000

Quarters > 0 > balance Sheet > cash

17753000

Quarters > 0 > balance Sheet > short Term Investments

14157000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

35606000

Quarters > 0 > balance Sheet > property Plant Equipment

21381000

Quarters > 0 > balance Sheet > total Assets

65053000

Quarters > 0 > balance Sheet > payables

1518000

Quarters > 0 > balance Sheet > short Term Debt

2700000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

32952000

Quarters > 0 > balance Sheet > equity

32101000

Quarters > 0 > cash Flow > net Income

-7144000

Quarters > 0 > cash Flow > depreciation

290000

Quarters > 0 > cash Flow > change In Working Capital

-3791000

Quarters > 0 > cash Flow > cash From Operations

-9732000

Quarters > 0 > cash Flow > capital Expenditures

72000

Quarters > 0 > cash Flow > cash From Investing

17884000

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

8152000

Quarters > 0 > ratios > PE

-3.7219169539464874

Quarters > 0 > ratios > PB

0.34680408086975484

Quarters > 0 > ratios > ROE

-22.25475841874085

Quarters > 0 > ratios > ROA

-10.98181482790955

Quarters > 0 > ratios > FCF

-9804000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-4.520055325034578

Quarters > 0 > health Score

23

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

1804000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

1804000

Quarters > 1 > income Statement > operating Expenses

11014000

Quarters > 1 > income Statement > operating Income

-9210000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-8561000

Quarters > 1 > income Statement > net Income

-8561000

Quarters > 1 > income Statement > eps

-4.4643671951143835

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

1917629

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-8863000

Quarters > 1 > income Statement > operating Margin

-510.53215077605324

Quarters > 1 > income Statement > total Other Income Expense Net

649000

Quarters > 1 > balance Sheet > cash

9601000

Quarters > 1 > balance Sheet > short Term Investments

25168000

Quarters > 1 > balance Sheet > receivables

700000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

38336000

Quarters > 1 > balance Sheet > property Plant Equipment

22235000

Quarters > 1 > balance Sheet > total Assets

75499000

Quarters > 1 > balance Sheet > payables

1852000

Quarters > 1 > balance Sheet > short Term Debt

2559000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

36657000

Quarters > 1 > balance Sheet > equity

38842000

Quarters > 1 > cash Flow > net Income

-8561000

Quarters > 1 > cash Flow > depreciation

347000

Quarters > 1 > cash Flow > change In Working Capital

-2462000

Quarters > 1 > cash Flow > cash From Operations

-9597000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

10793000

Quarters > 1 > cash Flow > cash From Financing

14000

Quarters > 1 > cash Flow > net Change In Cash

1210000

Quarters > 1 > ratios > PE

-4.4643671951143835

Quarters > 1 > ratios > PB

0.28634591936563514

Quarters > 1 > ratios > ROE

-22.04057463570362

Quarters > 1 > ratios > ROA

-11.339223036066704

Quarters > 1 > ratios > FCF

-9597000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-5.319844789356985

Quarters > 1 > health Score

29

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

1222000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

1222000

Quarters > 2 > income Statement > operating Expenses

13337000

Quarters > 2 > income Statement > operating Income

-12115000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-11040000

Quarters > 2 > income Statement > net Income

-11040000

Quarters > 2 > income Statement > eps

-0.28795219743129424

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

38339697

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-11716000

Quarters > 2 > income Statement > operating Margin

-991.4075286415712

Quarters > 2 > income Statement > total Other Income Expense Net

1075000

Quarters > 2 > balance Sheet > cash

8391000

Quarters > 2 > balance Sheet > short Term Investments

30447000

Quarters > 2 > balance Sheet > receivables

710000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

42509000

Quarters > 2 > balance Sheet > property Plant Equipment

23206000

Quarters > 2 > balance Sheet > total Assets

85862000

Quarters > 2 > balance Sheet > payables

1534000

Quarters > 2 > balance Sheet > short Term Debt

2400000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

39052000

Quarters > 2 > balance Sheet > equity

46810000

Quarters > 2 > cash Flow > net Income

-11040000

Quarters > 2 > cash Flow > depreciation

399000

Quarters > 2 > cash Flow > change In Working Capital

-3551000

Quarters > 2 > cash Flow > cash From Operations

-13365000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

14551000

Quarters > 2 > cash Flow > cash From Financing

-

Quarters > 2 > cash Flow > net Change In Cash

1186000

Quarters > 2 > ratios > PE

-0.28795219743129424

Quarters > 2 > ratios > PB

4.750485849177526

Quarters > 2 > ratios > ROE

-23.58470412305063

Quarters > 2 > ratios > ROA

-12.857841652884861

Quarters > 2 > ratios > FCF

-13365000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-10.936988543371521

Quarters > 2 > health Score

25

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

24092000

Quarters > 3 > income Statement > cost Of Revenue

426000

Quarters > 3 > income Statement > gross Profit

-426000

Quarters > 3 > income Statement > operating Expenses

15243000

Quarters > 3 > income Statement > operating Income

-15669000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-15936000

Quarters > 3 > income Statement > net Income

-15936000

Quarters > 3 > income Statement > eps

-0.4162412443983347

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

38285490

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-15510000

Quarters > 3 > income Statement > operating Margin

-65.03818695002491

Quarters > 3 > income Statement > total Other Income Expense Net

-267000

Quarters > 3 > balance Sheet > cash

7205000

Quarters > 3 > balance Sheet > short Term Investments

40118000

Quarters > 3 > balance Sheet > receivables

1165000

Quarters > 3 > balance Sheet > inventories

1

Quarters > 3 > balance Sheet > total Current Assets

50814000

Quarters > 3 > balance Sheet > property Plant Equipment

24895000

Quarters > 3 > balance Sheet > total Assets

99632000

Quarters > 3 > balance Sheet > payables

1507000

Quarters > 3 > balance Sheet > short Term Debt

2251000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

42434000

Quarters > 3 > balance Sheet > equity

57198000

Quarters > 3 > cash Flow > net Income

-15936000

Quarters > 3 > cash Flow > depreciation

426000

Quarters > 3 > cash Flow > change In Working Capital

-1196000

Quarters > 3 > cash Flow > cash From Operations

-14430000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

12232000

Quarters > 3 > cash Flow > cash From Financing

29000

Quarters > 3 > cash Flow > net Change In Cash

-2169000

Quarters > 3 > ratios > PE

-0.4162412443983347

Quarters > 3 > ratios > PB

3.8822308821986784

Quarters > 3 > ratios > ROE

-27.86111402496591

Quarters > 3 > ratios > ROA

-15.994861088806807

Quarters > 3 > ratios > FCF

-14430000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.5989540096297526

Quarters > 3 > health Score

26

Valuation > metrics > PE

-3.7219169539464874

Valuation > metrics > PB

0.34680408086975484

Valuation > final Score

70

Valuation > verdict

65.3% Undervalued

Profitability > metrics > ROE

-22.25475841874085

Profitability > metrics > ROA

-20.064034151547492

Profitability > metrics > Net Margin

-3.2936837252189948

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.026510077567677

Risk > metrics > Interest Coverage

-26.56206896551724

Risk > final Score

-76

Risk > verdict

High

Liquidity > metrics > Current Ratio

8.441441441441441

Liquidity > metrics > Quick Ratio

8.441441441441441

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

32.49514150822474

Prev Valuations > 2

41.17769117801322

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-74

Prev Risks > 1

-24

Prev Risks > 2

-99

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-12T14:40:21.681Z